Back to Capital Fund Management S.A. Capital Fund Management S.A.

VKTXVKTX

Showing 5 of 11 quarters

Position history for Capital Fund Management S.A.Capital Fund Management S.A.'s holdings in Viking Therapeutics, Inc.

Yes. Capital Fund Management holds 75,216 shares of VKTX (Viking Therapeutics), worth $2.9M, as of its Q2 2026 13F filing. It increased the position from 20,824 shares in Q1 2026. Capital Fund Management has held VKTX since Q4 2025, across 3 quarterly 13F filings.

Current Value

$2.9M

Current Shares

75,216

Total Value Change

-$1.9M

Total Shares Change

-551

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
75,216
+261.2%
$2.9M0.0%$39.01
42
2026-Q1
Increased
20,824
+77.6%
$677,6120.0%$32.54
37
2025-Q4
New
11,726
—
$412,5200.0%$35.18
33
2024-Q4
Exited
0
-100.0%
$00.0%$40.24
0
2024-Q3
Decreased
75,767
-6.2%
$4.8M0.0%$63.31
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used